TOMIO TAKEUCHI

991 total citations
37 papers, 793 citations indexed

About

TOMIO TAKEUCHI is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, TOMIO TAKEUCHI has authored 37 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Organic Chemistry and 12 papers in Pharmacology. Recurrent topics in TOMIO TAKEUCHI's work include Microbial Natural Products and Biosynthesis (7 papers), Cancer therapeutics and mechanisms (5 papers) and Peptidase Inhibition and Analysis (4 papers). TOMIO TAKEUCHI is often cited by papers focused on Microbial Natural Products and Biosynthesis (7 papers), Cancer therapeutics and mechanisms (5 papers) and Peptidase Inhibition and Analysis (4 papers). TOMIO TAKEUCHI collaborates with scholars based in Japan, United States and United Kingdom. TOMIO TAKEUCHI's co-authors include Kazuo Umezawa, MASA HAMADA, HIROSHI NAGANAWA, Masaya Imoto, KUNIO ISSHIKI, Hirohisa Tajima, Takashi Hori, Masaaki Ishizuka, Junichi Seki and Hiroo Hoshino and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Bioorganic & Medicinal Chemistry.

In The Last Decade

TOMIO TAKEUCHI

37 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
TOMIO TAKEUCHI Japan 16 411 332 208 114 79 37 793
Kazutoshi Mizoue Japan 21 361 0.9× 338 1.0× 303 1.5× 102 0.9× 63 0.8× 39 867
Morita Iwami Japan 18 453 1.1× 257 0.8× 213 1.0× 136 1.2× 71 0.9× 31 825
Kazuteru Yokose Switzerland 20 526 1.3× 429 1.3× 330 1.6× 155 1.4× 80 1.0× 44 984
Yoshihiro Nishikawa Japan 19 367 0.9× 260 0.8× 121 0.6× 119 1.0× 136 1.7× 95 1.0k
Tetsuo Ohnuki Japan 16 639 1.6× 395 1.2× 208 1.0× 82 0.7× 217 2.7× 32 1.1k
Toshifumi Takeuchi Japan 20 468 1.1× 234 0.7× 244 1.2× 121 1.1× 104 1.3× 69 991
Jens Breinholt Denmark 17 350 0.9× 330 1.0× 266 1.3× 147 1.3× 50 0.6× 40 1.1k
GERHARD HÖFLE Germany 8 247 0.6× 228 0.7× 268 1.3× 132 1.2× 54 0.7× 10 554
HEINRICH H. PETER Switzerland 18 273 0.7× 315 0.9× 266 1.3× 108 0.9× 73 0.9× 34 786
Rie Onose Japan 16 416 1.0× 400 1.2× 272 1.3× 132 1.2× 118 1.5× 24 919

Countries citing papers authored by TOMIO TAKEUCHI

Since Specialization
Citations

This map shows the geographic impact of TOMIO TAKEUCHI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by TOMIO TAKEUCHI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites TOMIO TAKEUCHI more than expected).

Fields of papers citing papers by TOMIO TAKEUCHI

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by TOMIO TAKEUCHI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by TOMIO TAKEUCHI. The network helps show where TOMIO TAKEUCHI may publish in the future.

Co-authorship network of co-authors of TOMIO TAKEUCHI

This figure shows the co-authorship network connecting the top 25 collaborators of TOMIO TAKEUCHI. A scholar is included among the top collaborators of TOMIO TAKEUCHI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with TOMIO TAKEUCHI. TOMIO TAKEUCHI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugimoto, Hikaru, Takao Kataoka, Masayuki Igarashi, et al.. (2000). E-73, an Acetoxyl Analogue of Cycloheximide, Blocks the Tumor Necrosis Factor-Induced NF-κB Signaling Pathway. Biochemical and Biophysical Research Communications. 277(2). 330–333. 20 indexed citations
2.
Igarashi, Masayuki, Chigusa Hayashi, Yoshiko Homma, et al.. (2000). Tubelactomicin A, a Novel 16-Membered Lactone Antibiotic, from Nocardia sp. I. Taxonomy, Production, Isolation and Biological Properties.. The Journal of Antibiotics. 53(10). 1096–1101. 34 indexed citations
3.
Matsumoto, Naoki, et al.. (2000). Inhibition of Rat Embryo Histidine Decarboxylase by Epoxyquinomicins.. The Journal of Antibiotics. 53(6). 637–639. 5 indexed citations
4.
Shitara, Eiki, Yoshio Nishimura, Fukiko Kojima, & TOMIO TAKEUCHI. (1999). A facile synthesis of d-glucose-type gem-diamine 1-N-iminosugars: a new family of glucosidase inhibitors. Bioorganic & Medicinal Chemistry. 7(6). 1241–1246. 23 indexed citations
5.
Matsumoto, Naoki, HIRONOBU IINUMA, TSUTOMU SAWA, & TOMIO TAKEUCHI. (1998). Synthesis of anti-rheumatic agent epoxyquinomicin B. Bioorganic & Medicinal Chemistry Letters. 8(21). 2945–2948. 5 indexed citations
6.
Momose, Isao, Naoko Kinoshita, Ryûichi Sawa, et al.. (1998). Nothramicin, a New Anthracycline Antibiotic from Nocardia sp. MJ896-43F17.. The Journal of Antibiotics. 51(2). 130–135. 12 indexed citations
7.
8.
Satoh, Takahiko, et al.. (1996). Synthesis and Antimetastatic Activity of 6-Trichloroacetamido and 6-Guanidino Analogues of Siastatin B.. The Journal of Antibiotics. 49(3). 321–325. 14 indexed citations
9.
Nishimura, Yoshio, et al.. (1994). Effect on spontaneous metastasis of mouse lewis lung carcinoma by a trifluoroacetamide analogue of siastatin B.. The Journal of Antibiotics. 47(7). 840–842. 15 indexed citations
10.
Oikawa, Tsutomu, Mariko Shimamura, Masami Hasegawa, et al.. (1993). Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase.. The Journal of Antibiotics. 46(5). 785–790. 7 indexed citations
11.
Igarashi, Masayuki, et al.. (1993). AB5046A and B, novel chlorosis-inducing substances from Nodulisporium sp.. The Journal of Antibiotics. 46(12). 1843–1848. 14 indexed citations
12.
Hatsu, Masahiro, et al.. (1992). Pyrizinostatin: A new inhibitor of pyroglutamyl peptidase.. The Journal of Antibiotics. 45(11). 1795–1796. 13 indexed citations
13.
Ajito, Katsuhiro, et al.. (1990). Improved antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin.. The Journal of Antibiotics. 43(11). 1464–1470. 2 indexed citations
14.
Hoshino, Hiroo, Junichi Seki, & TOMIO TAKEUCHI. (1989). New antifungal antibiotics, benanomicins A and B inhibit infection of T-cell with human immunodeficiency virus (HIV) and syncytium formation by HIV.. The Journal of Antibiotics. 42(2). 344–346. 47 indexed citations
15.
Hirono, Chikara, et al.. (1989). Herbimycin A Suppresses the Reduction of Gap‐junctional Intercellular Communication Induced by Tumor‐promoting Phorbol Ester in 3T3‐L1 Cells. Japanese Journal of Cancer Research. 80(9). 855–860. 2 indexed citations
17.
Abe, Fuminori, HIROSHI KURAMOCHI, Katsutoshi Takahashi, Masaaki Ishizuka, & TOMIO TAKEUCHI. (1988). Biological activity of the main metabolites of ubenimex in humans.. The Journal of Antibiotics. 41(12). 1862–1867. 3 indexed citations
18.
Takahashi, Katsutoshi, H Ekimoto, Kiyohiro Nishikawa, et al.. (1987). Liblomycin, a new analogue of bleomycin. Cancer Treatment Reviews. 14(3-4). 169–177. 16 indexed citations
19.
ISSHIKI, KUNIO, Masaya Imoto, TOMIO TAKEUCHI, et al.. (1987). Effective synthesis of erbstatin and its analogs.. The Journal of Antibiotics. 40(8). 1207–1208. 13 indexed citations
20.
Takahashi, Atsushi, SHOGO KURASAWA, Masaaki Ishizuka, et al.. (1987). Bisucaberin, a new siderophore, sensitizing tumor cells to macrophage-mediated cytolysis. I. Taxonomy of the producing organism, isolation and biological properties.. The Journal of Antibiotics. 40(12). 1664–1670. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026